Health utility measurement for people living with HIV/AIDS under combined antiretroviral therapy: A comparison of EQ-5D-5L and SF-6D
- PMID: 36397330
- PMCID: PMC9666157
- DOI: 10.1097/MD.0000000000031666
Health utility measurement for people living with HIV/AIDS under combined antiretroviral therapy: A comparison of EQ-5D-5L and SF-6D
Abstract
We compared the discriminative validity, agreement and sensitivity of EQ-5D-5L and SF-6D utility scores in people living with HIV/AIDS (PLWHIV). We conducted a cross-sectional survey among PLWHIV aged more than 18 years old in 9 municipalities in Yunnan Province, China. A convenience sample was enrolled. We administered the SF-12 and EQ-5D-5L to measure health-related quality of life. The utility index of the SF-6D was derived from the SF-12. We calculate correlation coefficients to evaluate the relationship and agreement of 2 instruments. To evaluate the homogeneity of the EQ-5D-5L and SF-6D, intraclass correlation coefficients, scatter plots, and Bland-Altman plots were computed and drawn. We also used receiver operating characteristic curves to compare the discriminative properties and sensitivity of the econometric index. A total of 1797 respondents, with a mean age of 45.6 ± 11.7 years, was interviewed. The distribution of EQ-5D-5L scores skewed towards full health with a skewness of -3.316. The overall correlation between EQ-5D-5L and SF-6D index scores was 0.46 (P < .001). The association of the 2 scales appeared stronger at the upper end. An intraclass correlation coefficient of 0.59 between the EQ-5D-5L and SF-6D meant a moderate correlation and indicated general agreement. The Bland-Altman plot displayed the same results as the scatter plot. The receiver operating characteristic curve showed that the AUC for the SF-6D was 0.776 (95% CI: 0.757, 0.796) and that for the EQ-5D-5L was 0.732 (95% CI: 0.712, 0.752) by the PCS-12, and it was 0.782 (95% CI: 0.763, 0.802) for the SF-6D and 0.690 (95% CI: 0.669, 0.711) for the EQ-5D-5L by the MCS-12. Our study demonstrated evidence of the performance of EQ-5D-5L and SF-6D index scores to measure health utility in people living with HIV/AIDS. There were significant differences in their performance. We preferred to apply the SF-6D to measure the health utility of PLWHIV during the combined antiretroviral therapy period. Our study has demonstrated evidence for instrument choice and preference measurements in PLWHIV under combined antiretroviral therapy.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors declare that they have no competing interest.
Figures






Similar articles
-
A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.J Med Econ. 2022 Jan-Dec;25(1):829-839. doi: 10.1080/13696998.2022.2087409. J Med Econ. 2022. PMID: 35674412
-
A comparative study of Chinese medicine quality of life assessment scale (CQ-11D) and EQ-5D-5L and SF-6D scales based on Chinese population.Qual Life Res. 2024 Jan;33(1):113-122. doi: 10.1007/s11136-023-03512-z. Epub 2023 Sep 11. Qual Life Res. 2024. PMID: 37695478 Free PMC article.
-
A Head-to-Head Comparison of UK SF-6D and Thai and UK EQ-5D-5L Value Sets in Thai Patients with Chronic Diseases.Appl Health Econ Health Policy. 2017 Oct;15(5):669-679. doi: 10.1007/s40258-017-0320-3. Appl Health Econ Health Policy. 2017. PMID: 28290106
-
A review of the psychometric properties of generic utility measures in multiple sclerosis.Pharmacoeconomics. 2014 Aug;32(8):759-73. doi: 10.1007/s40273-014-0167-5. Pharmacoeconomics. 2014. PMID: 24846760 Review.
-
Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain.Health Qual Life Outcomes. 2013 Jul 1;11:110. doi: 10.1186/1477-7525-11-110. Health Qual Life Outcomes. 2013. PMID: 23815777 Free PMC article. Review.
Cited by
-
Health-related quality of life of HIV patients with comorbidities of hypertension or diabetes in Ghana.Front Public Health. 2024 Nov 19;12:1383743. doi: 10.3389/fpubh.2024.1383743. eCollection 2024. Front Public Health. 2024. PMID: 39628805 Free PMC article.
-
How to Assess Health Gains.Healthcare (Basel). 2025 Apr 5;13(7):832. doi: 10.3390/healthcare13070832. Healthcare (Basel). 2025. PMID: 40218129 Free PMC article.
-
An international compendium of health state utilities in people with HIV: a systematic review.Qual Life Res. 2025 Apr 17. doi: 10.1007/s11136-025-03966-3. Online ahead of print. Qual Life Res. 2025. PMID: 40246804 Review.
References
-
- Xinhua.net. Yunnan has achieved the goal of three 90% for HIV prevention. Available at: https://baijiahao.baidu.com/s?id=1684890263547198748&wfr=spider&for=pc [access date January 19, 2021].
-
- Yunnan CN. Yunnan held the briefing of AIDS epidemic and prevention progress [EB/OL]. Available at: http://m.yunnan.cn/system/2020/12/01/031153259.shtml [access date January 19, 2021].
-
- Morad G, Noureddine E, Aicha B, et al. . Assessment of quality of life in children, adolescents, and adults with celiac disease through specific questionnaires: review. Nutr Clinique et Métabolisme. 2020;34:194–200.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical